Insider Buying: DelMar Pharmaceuticals Director Acquires 9,000 Shares of Stock (DMPI)
DelMar Pharmaceuticals (NASDAQ:DMPI) Director Robert Joseph Toth, Jr. acquired 9,000 shares of the company’s stock in a transaction dated Wednesday, February 5th. The shares were purchased at an average cost of $0.88 per share, with a total value of $7,920.00. Following the completion of the transaction, the director now directly owns 18,500 shares in the company, valued at approximately $16,280. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
DelMar Pharmaceuticals (NASDAQ:DMPI) traded up 11.76% on Friday, hitting $0.95. The stock had a trading volume of 38,200 shares. DelMar Pharmaceuticals has a one year low of $0.751 and a one year high of $2.50. The stock’s 50-day moving average is $0.91 and its 200-day moving average is $1.0. The company’s market cap is $22.8 million.
DelMar Pharmaceuticals, Inc formerly Berry Only Inc, is developing new drug candidates targeting orphan cancer indications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.